News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,040 Results
Type
Article (48745)
Company Profile (319)
Press Release (704953)
Multimedia
Podcasts (116)
Webinars (23)
Section
Business (210079)
Career Advice (2242)
Deals (36220)
Drug Delivery (148)
Drug Development (82886)
Employer Resources (197)
FDA (16715)
Job Trends (15394)
News (354563)
Policy (33500)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2789)
Academic (2)
Accelerated approval (47)
Adcomms (29)
Allergies (173)
Alliances (51179)
ALS (214)
Alzheimer's disease (1847)
Antibody-drug conjugate (ADC) (453)
Approvals (17076)
Artificial intelligence (699)
Autoimmune disease (295)
Automation (57)
Bankruptcy (369)
Best Places to Work (11835)
BIOSECURE Act (21)
Biosimilars (222)
Biotechnology (199)
Bladder cancer (188)
Brain cancer (71)
Breast cancer (757)
Cancer (5857)
Cardiovascular disease (475)
Career advice (1910)
Career pathing (48)
CAR-T (343)
CDC (63)
Celiac Disease (3)
Cell therapy (928)
Cervical cancer (48)
Clinical research (71592)
Collaboration (2118)
Company closure (5)
Compensation (1391)
Complete response letters (81)
COVID-19 (2824)
CRISPR (111)
C-suite (1155)
Cystic fibrosis (153)
Data (7894)
Decentralized trials (3)
Denatured (45)
Depression (164)
Dermatology (85)
Diabetes (591)
Diagnostics (7087)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (335)
Drug pricing (211)
Drug shortages (32)
Duchenne muscular dystrophy (289)
Earnings (92981)
Editorial (70)
Employer branding (25)
Employer resources (167)
Events (123208)
Executive appointments (1113)
FDA (20449)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1773)
Gene editing (244)
Generative AI (60)
Gene therapy (748)
GLP-1 (1103)
Government (4901)
Grass and pollen (6)
Guidances (409)
Healthcare (19402)
HIV (81)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (99)
Immunology and inflammation (296)
Immuno-oncology (93)
Indications (191)
Infectious disease (3166)
Inflammatory bowel disease (224)
Inflation Reduction Act (16)
Influenza (137)
Intellectual property (293)
Interviews (360)
IPO (16893)
IRA (52)
Job creations (3860)
Job search strategy (1595)
JPM (62)
Kidney cancer (19)
Labor market (108)
Layoffs (590)
Leadership (44)
Legal (8119)
Liver cancer (100)
Longevity (32)
Lung cancer (770)
Lymphoma (432)
Machine learning (62)
Management (63)
Manufacturing (1067)
MASH (190)
Medical device (14092)
Medtech (14214)
Mergers & acquisitions (20572)
Metabolic disorders (1527)
mRNA (214)
Multiple sclerosis (189)
NASH (23)
Neurodegenerative disease (430)
Neuropsychiatric disorders (107)
Neuroscience (3384)
Neurotech (1)
NextGen: Class of 2026 (6735)
Non-profit (4705)
Now hiring (79)
Obesity (721)
Opinion (313)
Ovarian cancer (222)
Pain (259)
Pancreatic cancer (302)
Parkinson's disease (366)
Partnered (35)
Patents (598)
Patient recruitment (673)
Peanut (64)
People (61680)
Pharmaceutical (69)
Pharmacy benefit managers (32)
Phase 1 (22320)
Phase 2 (31520)
Phase 3 (23460)
Pipeline (8688)
Policy (333)
Postmarket research (2648)
Preclinical (9743)
Press Release (72)
Prostate cancer (300)
Psychedelics (57)
Radiopharmaceuticals (326)
Rare diseases (1091)
Real estate (6295)
Recruiting (77)
Regulatory (25878)
Reports (72)
Research institute (2576)
Resumes & cover letters (380)
Rett syndrome (39)
RNA editing (22)
RSV (90)
Schizophrenia (181)
Series A (302)
Series B (218)
Service/supplier (13)
Sickle cell disease (116)
Special edition (26)
Spinal muscular atrophy (169)
Sponsored (49)
Startups (3852)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (87)
The Weekly (69)
Vaccines (1131)
Venture capital (113)
Weight loss (471)
Women's health (126)
Worklife (23)
Date
Today (210)
Last 7 days (938)
Last 30 days (3642)
Last 365 days (30850)
2026 (12513)
2025 (30751)
2024 (35948)
2023 (40870)
2022 (51944)
2021 (56522)
2020 (54922)
2019 (47699)
2018 (35967)
2017 (33116)
2016 (32692)
2015 (38794)
2014 (32402)
2013 (27579)
2012 (29834)
2011 (30561)
2010 (29073)
Location
Africa (822)
Alabama (94)
Alaska (7)
Arizona (359)
Arkansas (15)
Asia (41438)
Australia (6843)
California (13335)
Canada (3779)
China (1349)
Colorado (577)
Connecticut (578)
Delaware (405)
Europe (90749)
Florida (1987)
Georgia (437)
Hawaii (4)
Idaho (63)
Illinois (1068)
India (91)
Indiana (612)
Iowa (24)
Japan (541)
Kansas (134)
Kentucky (53)
Louisiana (41)
Maine (75)
Maryland (1600)
Massachusetts (9605)
Michigan (385)
Minnesota (741)
Mississippi (7)
Missouri (146)
Montana (33)
Nebraska (29)
Nevada (145)
New Hampshire (86)
New Jersey (3536)
New Mexico (31)
New York (3507)
North Carolina (1739)
North Dakota (11)
Northern California (6669)
Ohio (403)
Oklahoma (24)
Oregon (42)
Pennsylvania (2675)
Puerto Rico (29)
Rhode Island (50)
South America (1191)
South Carolina (85)
South Dakota (2)
Southern California (5252)
Tennessee (213)
Texas (2137)
United States (47339)
Utah (400)
Vermont (1)
Virginia (327)
Washington D.C. (85)
Washington State (1071)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
754,040 Results for "sight sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sight Sciences to Present at Two Upcoming May 2026 Investor Conferences
April 29, 2026
·
2 min read
Press Releases
Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026
April 22, 2026
·
2 min read
Press Releases
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
May 7, 2026
·
15 min read
Press Releases
Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th
March 30, 2026
·
2 min read
Job Trends
The Next Cambridge? LA Sets Its Sights Higher
The Los Angeles region is one of California’s fastest-growing life sciences hubs, according to a California Life Sciences sector report. The CEO of BioscienceLA discusses the market’s strengths, challenges and where it might be five years from now.
March 12, 2026
·
5 min read
·
Angela Gabriel
Press Releases
Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
February 18, 2026
·
2 min read
Press Releases
Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
April 2, 2026
·
5 min read
Press Releases
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance
March 5, 2026
·
16 min read
Press Releases
NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist
May 11, 2026
·
4 min read
Press Releases
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
January 13, 2026
·
7 min read
1 of 75,404
Next
